This Key Indicator Spots A Trade In A Wild Week

Last week, I discussed using the VIX and derivative analysis of the VIX to predict market direction. This week, I Last week, I discussed using the VIX and derivative analysis of the VIX to predict market direction. This week, I’m going to hammer home this concept. Why? Because it’s telling me a story that may give me an edge and confidence in my directional market predictions in the coming days and weeks. The market simply doesn’t have a clear direction here, as seen in the ETF SPY: After bouncing back to the 50-Day Moving Average, the market is pulling back. Is this setting up a bear flag and a liquidation, a short-term buying opportunity, or a choppy market with no real direction? For now, there’s a wedge between the 50-Day Moving Average and the 100-Day Moving Average that should clarify things in the near future. But I’m going to try to get ahead of this and look for an indicator of which direction is more likely given the current market inputs. [When you know these key setups, spotting the lucrative Outlier trades gets crazy easy. Click here for your Outlier Roadmap.]( As I mentioned last week, when VVIX is low and shows no indications of rising, it tends to predict a low VIX and a drifting higher market. So, let’s look at VVIX: VVIX continues to trade near lows, and if the recent cycles have been any indication, I would not be surprised to see VVIX stay around these levels for another week or so. If the market is to get a pullback, the VIX and VVIX would, of course, be expected to spike. But given the lack of interest in buying options here on a market-wide scale, I lean towards an expectation of implied volatility staying low and the market drifting higher. Let’s not forget to look at the VIX itself: The VIX is also trading at lows and looks to be confirming what I’m seeing in VVIX – low implied volatility, little market panic, and a potential for a bullish bias in the broad market as a result. When I see that kind of setup, I certainly look at potential sectors to put on the buy list in my Outlier Watch List. And this time is no different. I’ll go back to a sector I looked at recently, biotech, with the ETF XBI: With clear support at the 200-Day Moving Average, a potential for a turn around with the move above the 10-Day Moving Average, and an expectation for a bullish broad market backdrop, I am getting excited about looking at more biotech names that can be leveraged with options. As always, please go to []( to review how I traditionally apply technical signals, volatility analysis, and probability analysis to my options trades. And if you have any questions, never hesitate to reach out. Keith Harwood Keith@optionhotline.com --------------------------------------------------------------- See Related Articles on [TradewinsDaily.com]( [This Key Indicator Spots A Trade In A Wild Week]( [A Big Market Day With These Big Opportunities]( [Chart of the Day: Nio Inc. (NIO)]( [Red Hot ‘Buy’ for Wingstop]( [This Set Up Flips The Odds Against The House]( --------------------------------------------------------------- [TradeWins Logo]( © 2024 Tradewins Publishing. All rights reserved. | [Privacy Policy]( | [Terms and Conditions]( | [Contact Us]( Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC's website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading. 1. The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the "Services") is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing ("TradeWins") a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis. 2. TradeWins' Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services. 3. Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services ("Subscriber") should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber. 4. You should trade or invest only "risk capital" money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more. 5. All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities. 6. Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown. 7. No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses. 8. The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber's own election and for the Subscriber's own risk. To unsubscribe from Market Wealth Daily [click here](